Pulsenmore (PLSM) Cash & Current Investments (2025)
Pulsenmore (PLSM) reported Cash & Current Investments of $21.7 million for Q4 2025.
Pulsenmore (PLSM) Cash & Current Investments (2025) Analysis & Trends
Pulsenmore (PLSM) has 1 years of Cash & Current Investments data on file, last reported at $21.7 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Current Investments changed N/A year-over-year to $21.7 million; the trailing twelve-month figure through Dec 2025 stood at $21.7 million (changed N/A YoY), and the FY2025 full-year result was $21.7 million, changed N/A from the prior year.
- Cash & Current Investments held at $21.7 million in Q4 2025.
- In the past five years, Cash & Current Investments ranged from a high of $21.7 million in Q4 2025 to a low of $21.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Pulsenmore | 21.20 Mn | -475,526.64 | - | 21.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.67 Mn |